AMG Stock Analysis: Affiliated Managers | NYSE
Asset Management | NYSE, USA | Market Cap: 9.952m USD | 12M Return: 71.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 95.0M
EPS Trend: 49.5%
Qual. Beats: 0
Rev. Trend: 44.8%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Affiliated Managers Group, Inc. (AMG) is a US-based investment management company that operates through a multi-affiliate model, providing advisory and sub-advisory services to mutual funds, institutional clients, retail investors, and high-net-worth individuals. The firm distributes its funds through intermediaries such as independent advisors, retirement plan sponsors, broker-dealers, fund marketplaces, and bank trust departments, and offers a broad range of strategies spanning value and growth equities across small, mid, and large capitalizations, emerging markets, quantitative, alternative, and fixed income products. AMG also manages assets for foundations, endowments, and corporate and municipal retirement plans, in addition to providing customized investment counseling and fiduciary services.
Founded in 1993 and headquartered in West Palm Beach, Florida, AMG maintains a global footprint with offices in the US, UK, UAE, Australia, Hong Kong, Japan, and Switzerland. Listed on the NYSE in 1997, the company sits within the Financials sectors Asset Management & Custody Banks sub-industry, distinguishing itself through a decentralized structure in which each affiliate retains investment autonomy while benefiting from AMGs centralized distribution, operations, and capital support.
- Equity market performance drives AUM and fee revenue
- Active management outflows pressure fee-based earnings growth
- Alternative and fixed income products expand higher-fee mix
| Net Income: 754.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 0.74 > 1.0 |
| NWC/Revenue: 6.34% < 20% (prev 35.95%; Δ -29.61% < -1%) |
| CFO/TA 0.11 > 3% & CFO 1.08b > Net Income 754.7m |
| Net Debt (2.54b) to EBITDA (1.53b): 1.66 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.5m) vs 12m ago -15.64% < -2% |
| Gross Margin: 68.14% > 18% (prev 55.58%; Δ 12.56% > 0.5%) |
| Asset Turnover: 26.13% > 50% (prev 23.38%; Δ 2.75% > 0%) |
| Interest Coverage Ratio: 9.90 > 6 (EBIT TTM 1.39b / Interest Expense TTM 140.8m) |
| A: 0.02 (Total Current Assets 1.25b - Total Current Liabilities 1.10b) / Total Assets 9.40b |
| B: 0.82 (Retained Earnings 7.73b / Total Assets 9.40b) |
| C: 0.15 (EBIT TTM 1.39b / Avg Total Assets 9.06b) |
| D: 0.60 (Book Value of Equity 3.09b / Total Liabilities 5.15b) |
| Altman-Z'' = 4.45 = AA |
| DSRI: 1.29 (Receivables 871.4m/581.7m, Revenue 2.37b/2.04b) |
| GMI: 0.82 (GM 55.58% / 68.14%) |
| AQI: 1.03 (AQ_t 0.86 / AQ_t-1 0.83) |
| SGI: 1.16 (Revenue 2.37b / 2.04b) |
| TATA: -0.03 (NI 754.7m - CFO 1.08b) / TA 9.40b) |
| Beneish M = -2.82 (Cap -4..+1) = A |
As of July 28, 2026, the stock is trading at USD 363.80 with a total of 158,100 shares traded. Over the past week, the price has changed by -0.63%, over one month by +6.23%, over three months by +24.78% and over the past year by +71.17%.
Current recommended Stop Loss: 347.50 (which is 4.5% or 1.3 ATR below the current price).
Affiliated Managers has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy AMG.
- StrongBuy: 3
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 412 | 13.2% |
P/E Trailing = 15.1756
P/E Forward = 10.582
P/S = 5.5273
P/B = 3.1614
P/EG = 0.9405
Revenue TTM = 2.37b USD
EBIT TTM = 1.39b USD
EBITDA TTM = 1.53b USD
Long Term Debt = 2.92b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.92b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.54b USD (calculated: Debt 2.92b - CCE 376.1m)
Enterprise Value = 12.5b USD (9.95b + Debt 2.92b - CCE 376.1m)
Interest Coverage Ratio = 9.90 (Ebit TTM 1.39b / Interest Expense TTM 140.8m)
EV/FCF = 11.67x (Enterprise Value 12.5b / FCF TTM 1.07b)
FCF Yield = 8.57% (FCF TTM 1.07b / Enterprise Value 12.5b)
FCF Margin = 45.22% (FCF TTM 1.07b / Revenue TTM 2.37b)
Net Margin = 31.89% (Net Income TTM 754.7m / Revenue TTM 2.37b)
Gross Margin = 68.14% ((Revenue TTM 2.37b - Cost of Revenue TTM 754.0m) / Revenue TTM)
Gross Margin QoQ = 81.02% (prev 83.33%)
Tobins Q-Ratio = 1.33 (Enterprise Value 12.5b / Total Assets 9.40b)
Interest Expense / Debt = 4.82% (Interest Expense 140.8m / Debt 2.92b)
Taxrate = 24.06% (301.4m / 1.25b)
NOPAT = 1.06b (EBIT 1.39b * (1 - 24.06%))
Current Ratio = 1.14 (Total Current Assets 1.25b / Total Current Liabilities 1.10b)
Debt / Equity = 0.94 (Debt 2.92b / totalStockholderEquity, last quarter 3.09b)
Debt / EBITDA = 1.66 (Net Debt 2.54b / EBITDA 1.53b)
Debt / FCF = 2.38 (Net Debt 2.54b / FCF TTM 1.07b)
Total Stockholder Equity = 3.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.33% (Net Income 754.7m / Total Assets 9.40b)
RoE = 23.38% (Net Income TTM 754.7m / Total Stockholder Equity 3.23b)
RoCE = 22.67% (EBIT 1.39b / Capital Employed (Equity 3.23b + L.T.Debt 2.92b))
RoIC = 12.94% (NOPAT 1.06b / Invested Capital 8.18b)
WACC = 8.44% (E(9.95b)/V(12.9b) * Re(9.84%) + D(2.92b)/V(12.9b) * Rd(4.82%) * (1-Tc(0.24)))
Discount Rate = 9.84% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.40 | Cagr: -16.54%
[DCF] Terminal Value 77.68% ; FCFF base≈1.01b ; Y1≈1.16b ; Y5≈1.71b
[DCF] Fair Price = 862.7 (EV 25.3b - Net Debt 2.54b = Equity 22.8b / Shares 26.4m; r=8.44% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 49.51 | EPS CAGR: 6.88% | SUE: 0.32 | # QB: 0
Revenue Correlation: 44.83 | Revenue CAGR: 2.73% | SUE: -0.00 | # QB: 0
EPS current Quarter (2026-06-30): EPS=7.92 | Chg30d=+2.01% | Revisions=+57% | Analysts=6
EPS next Quarter (2026-09-30): EPS=8.14 | Chg30d=+4.44% | Revisions=+57% | Analysts=5
EPS current Year (2026-12-31): EPS=35.89 | Chg30d=+2.94% | Revisions=+62% | GrowthEPS=+37.8% | GrowthRev=+15.4%
EPS next Year (2027-12-31): EPS=28.22 | Chg30d=+6.70% | Revisions=+40% | GrowthEPS=+13.6% | GrowthRev=+11.3%
[Analyst] Revisions Ratio: +83% (up=15, down=0)